Vijaya Diagnostic Centre Limited has informed the Exchange about Scrutinizer's report along with voting results of the NCLT convened meeting of unsecured creditors.
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts less than Nifty Smallcap 250 and 0.8 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vijaya Diagnostic Centre Limited held an NCLT-ordered meeting of its unsecured creditors on April 25, 2025, to seek approval for a Scheme of Amalgamation with Medinova Diagnostic Services Limited (Transferor Company), with Vijaya being the Transferee Company. Of the 234 unsecured creditors on record, 19 voted, representing an outstanding amount of Rs 39,53,26,503 (88.30% of total unsecured debt). All 19 creditors voted 100% in favour of the scheme, and the resolution was passed with the requisite majority. The Scrutinizer confirmed the e-voting process was fair and transparent. The scheme, effective from April 1, 2024, is now one step closer to final NCLT sanction. Shareholders and equity holders will have separate meetings/court processes ahead.
This is a procedural milestone in the merger process, not a negative event. Approval by unsecured creditors removes a key hurdle and moves the amalgamation closer to final NCLT sanction, which could be modestly positive for Vijaya Diagnostic shareholders once the merger completes. No immediate impact on share price is expected from this disclosure alone.